Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2% Povidone-iodine for Epidemic Keratoconjunctivitis
NCT01179412Phase 4Completed
- Sponsor
- Mahidol University
- Start
- Jul 2004
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of povidone-iodine in epidemic keratoconjunctivitis (EKC), sponsored by Mahidol University. Primary endpoint: Recovery rate within one week of treatment at 1 week. Started Jul 2004; status: completed.
02
Drugs
povidone-iodine
03
Conditions
epidemic keratoconjunctivitis (EKC)
Beyond the preview
Go deeper on NCT01179412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01179412.